StemCells, Inc. (Nasdaq: STEM) announced that it has completed enrollment of the first of two planned patient cohorts in the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE